StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · UPC·Healthcare

Universe Pharmaceuticals Inc. Stock Analysis & AI Score

Universe Pharmaceuticals Inc. (UPC) has an ST Score of 45.2 (C+), driven by its Financial Strength (A) and held back by its Growth (F). UPC last traded at $4.68.

Market Closed
$4.68
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
45
ST Score
45.2/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

UPC
45.2out of 100
Grade C+

Universe Pharmaceuticals Inc. (UPC) has an ST Score of 45.2 (C+), driven by its Financial Strength (A) and held back by its Growth (F). UPC last traded at $4.68.

Strongest
Financial StrengthA
Weakest
GrowthF
All factor grades
  • Financial StrengthA
  • ValuationB
  • MomentumB-
  • ProfitabilityC+
  • GrowthF
  • Piotroski2/9
Score methodology
Press Releases

Contact

UPC stock: frequently asked questions

What is UPC's ST Score?

Universe Pharmaceuticals Inc. (UPC) has an ST Score of 45.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is UPC a buy, hold, or sell?

Our ST Score grades it C+ (45.2/100). The ST Score is a data-driven signal, not a recommendation.

What are UPC's factor grades?

Valuation B, Profitability C+, Financial Strength A, Momentum B-, Growth F.

What is UPC's valuation grade?

Universe Pharmaceuticals Inc. (UPC) earns a valuation grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is UPC's growth grade?

Universe Pharmaceuticals Inc. (UPC) earns a growth grade of F, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is UPC's profitability grade?

Universe Pharmaceuticals Inc. (UPC) earns a profitability grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is UPC's financial strength grade?

Universe Pharmaceuticals Inc. (UPC) earns a financial strength grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is UPC's Piotroski score?

Universe Pharmaceuticals Inc. (UPC) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.